Developing vaccines and therapies for the highly pathogenic Nipah and Hendra viruses Bethesda, Maryland, March 25, 2019 (GLOBE NEWSWIRE) -- Bethesda, MD, March 20, 2019 – The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), along with Uniformed...

CEPI、ニパウィルスのワクチン開発に向けて、プロフェクタス･バイオサイエンスおよびエマージェント･バイオソリューションと、2,500万ドル (約27億円) の契約を締結 日 オスロ (ノルウェー)、ボルティモアおよびメリーランド州ゲイサーズバーグ発, May 28, 2018 (GLOBE NEWSWIRE) -- CEPI (伝染病蔓延対策の革新のための連合、Coalition for Epidemic Preparedness Innovations) は本日、プロフェクタス･バイオサイエンス (Profectus BioSciences, Inc.)...

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 27, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus...

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 24, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus...